Highly efficient NRF2 activators-co-releasing molecule hybrids, their use in the treatment of inflammatory or cardiovascular diseases and their process of preparation
US-10519179-B2 · Dec 31, 2019 · US
Rivard Michael is listed as an inventor on 12 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Rivard Michael |
| Total patents | 12 |
| First publication | Jul 7, 2015 |
| Latest publication | Dec 31, 2019 |
Publications ranked by popularity score, then publication date.
US-10519179-B2 · Dec 31, 2019 · US
US-10125157-B2 · Nov 13, 2018 · US
US-10098901-B2 · Oct 16, 2018 · US
US-2018258121-A1 · Sep 13, 2018 · US
US-9944669-B2 · Apr 17, 2018 · US
US-2017360964-A1 · Dec 21, 2017 · US
US-2017174716-A1 · Jun 22, 2017 · US
US-2017071959-A1 · Mar 16, 2017 · US
US-2016333038-A1 · Nov 17, 2016 · US
US-9428530-B2 · Aug 30, 2016 · US
Latest publications not already listed above.
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Roussy Inst Gustave | 7 |
| Centre Nat Rech Scient | 4 |
| Univ Paris Val De Marne | 4 |
| Inst Nat Sante Rech Med | 2 |
| Univ Paris-Est Creteil Val De Marne | 1 |
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| A61P35/00 | 7 |
| C07F9/65846 | 7 |
| A61K47/6851 | 5 |
| A61P37/06 | 5 |
| C07K16/30 | 5 |